Difference between revisions of "Niacin/lovastatin"

From Self-sufficiency
Jump to: navigation, search
 
m (1 revision)
 
(No difference)

Latest revision as of 15:50, 19 September 2010

Niacin/lovastatin
File:Niacinstr.png
File:Lovastatin.png
Combination of
Niacin n/a
Lovastatin Statin
Clinical data
Pregnancy
category
  • US: X (Contraindicated)
Routes of
administration		 Oral
Legal status
Legal status
Identifiers
ATC code C10BA01 (WHO)
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Niacin/lovastatin (tradename Advicor) is a drug combination used for the treatment of dyslipidemia. It is a combination of niacin and the statin drug lovastatin (best known as Mevacor in the U.S.). The combination preparation is marketed by Abbott Laboratories

It was approved by the FDA on December 17, 2001.

Dosage

The combination is available as tablets containing:.[1]

  • 500 mg/20 mg
  • 750 mg/20 mg
  • 1000 mg/20 mg
  • 1000 mg/40 mg

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />

External links

GI tract
Liver
Niacin and derivatives (HDL and LDL)
Blood vessels
Combinations
Other

M: MET

mt, a/u/y/n/h, r/g/c/p/i, f/s/l/o, m

au/y/n/h, rgcp/i, f/s/l/o, m, epon

meds(A16, C10),intm(a/u/y/n/h, r/g/c/p/i, f/s/o)

30px This drug article relating to the cardiovascular system is a stub. You can help ssf by expanding it.
  1. ↑ "Advicor package insert, How Supplied section". Retrieved 2008-03-15. 
Retrieved from "http://ssf.f15ijp.com/wiki/index.php?title=Niacin/lovastatin&oldid=22669"